Generics News
-
Mylan launches generic version of Sporanox
Generics | Regulatory | By BioSpectrum Bureau | 4 Comment | 30 Jul, 2012
Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...Read more
-
Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...Read more
-
AstraZeneca, BMS gets FDA nod for diabetes drug
Generics | Regulatory | By BioSpectrum Bureau | 4 Comment | 09 Jan, 2014
Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...Read more
-
Ranbaxy advisory: All our products are safe and efficacious
Generics | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...Read more
-
Rabies claims 100 lives annually in Vietnam: UN
Generics | Analysis | By BioSpectrum Bureau | 3 Comment | 30 Sep, 2013
Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...Read more
-
Now Ranbaxy's Mohali unit under FDA scanner
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2013
Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...Read more
-
Mundipharma, Shionogi tie up for pain treatment in Japan
Generics | News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2013
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...Read more
-
GSK files for approval on melanoma drug combo
Generics | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...Read more
-
TB prevention faces gap of $1.6bn: WHO estimates
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...Read more
-
Avanir Pharma settles patent litigation with Wockhardt
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...Read more
-
TWi Pharma gets FDA nod for ADHD drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 15 May, 2013
Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...Read more
-
Sandoz launches trial with Amgen biosimilar
Generics | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...Read more
-
US company leverages on generics
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...Read more
-
NATCO wins compulsory license for anti-cancer drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...Read more
-
Mylan gets FDA nod for Thiamine Hydrochloride Injection
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...Read more
-
Big pharma to drive R&D innovation with $4.4 bn
Generics | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...Read more
-
Multiple organzations join hands to curb fake drug business
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...Read more
-
Arvind sets up $42.37 mn plant top tap US market
Generics | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...Read more
